0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immune in Vitro Diagnostics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-36S16577
Home | Market Reports | Health| Reproductive Health
Global Immune in Vitro Diagnostics Market Research Report 2024
BUY CHAPTERS

Global Immune in Vitro Diagnostics Market Research Report 2025

Code: QYRE-Auto-36S16577
Report
September 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Immune in Vitro Diagnostics Market Size

The global market for Immune in Vitro Diagnostics was valued at US$ 25060 million in the year 2024 and is projected to reach a revised size of US$ 39610 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Immune in Vitro Diagnostics Market

Immune in Vitro Diagnostics Market

Immune in vitro diagnostics (IVD) involve the examination of components related to the immune system, often using laboratory tests performed on biological samples taken from the human body. These tests play a crucial role in understanding the immune response, diagnosing immunological disorders, monitoring the effectiveness of treatments, and assessing overall immune health.
The Immune In Vitro Diagnostics market is propelled by a growing demand for advanced diagnostic tools to assess the immune system"s functionality and response. With the increasing incidence of immune-related disorders, including autoimmune diseases and allergies, there is a heightened need for accurate and timely diagnostics. Immune in vitro diagnostic devices, such as immunoassays, flow cytometry, and molecular diagnostics, play a crucial role in evaluating immune biomarkers. The market is driven by ongoing research in immunology, leading to the development of more specific and sensitive diagnostic technologies. Additionally, a focus on personalized medicine and treatment strategies contributes to the continuous evolution and adoption of immune in vitro diagnostics in clinical practice.
This report aims to provide a comprehensive presentation of the global market for Immune in Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune in Vitro Diagnostics.
The Immune in Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune in Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune in Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Immune in Vitro Diagnostics Market Report

Report Metric Details
Report Name Immune in Vitro Diagnostics Market
Accounted market size in year US$ 25060 million
Forecasted market size in 2031 US$ 39610 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Consumables
  • Equipment
Segment by Application
  • Hepatitis Test
  • STD Testing
  • Tumor Detection
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, KHB, Daan Gene, Leadman, Zhongsheng, Bsbe, Maccura, Hitachi, Canon, Sysmex, Auto Bio, Mindray, Bgi, Wondfo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Immune in Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Immune in Vitro Diagnostics Market growing?

Ans: The Immune in Vitro Diagnostics Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Immune in Vitro Diagnostics Market size in 2031?

Ans: The Immune in Vitro Diagnostics Market size in 2031 will be US$ 39610 million.

Who are the main players in the Immune in Vitro Diagnostics Market report?

Ans: The main players in the Immune in Vitro Diagnostics Market are Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, KHB, Daan Gene, Leadman, Zhongsheng, Bsbe, Maccura, Hitachi, Canon, Sysmex, Auto Bio, Mindray, Bgi, Wondfo

What are the Application segmentation covered in the Immune in Vitro Diagnostics Market report?

Ans: The Applications covered in the Immune in Vitro Diagnostics Market report are Hepatitis Test, STD Testing, Tumor Detection, Other

What are the Type segmentation covered in the Immune in Vitro Diagnostics Market report?

Ans: The Types covered in the Immune in Vitro Diagnostics Market report are Consumables, Equipment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune in Vitro Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Consumables
1.2.3 Equipment
1.3 Market by Application
1.3.1 Global Immune in Vitro Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hepatitis Test
1.3.3 STD Testing
1.3.4 Tumor Detection
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune in Vitro Diagnostics Market Perspective (2020-2031)
2.2 Global Immune in Vitro Diagnostics Growth Trends by Region
2.2.1 Global Immune in Vitro Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Immune in Vitro Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Immune in Vitro Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Immune in Vitro Diagnostics Market Dynamics
2.3.1 Immune in Vitro Diagnostics Industry Trends
2.3.2 Immune in Vitro Diagnostics Market Drivers
2.3.3 Immune in Vitro Diagnostics Market Challenges
2.3.4 Immune in Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune in Vitro Diagnostics Players by Revenue
3.1.1 Global Top Immune in Vitro Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Immune in Vitro Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Immune in Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immune in Vitro Diagnostics Revenue
3.4 Global Immune in Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Immune in Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune in Vitro Diagnostics Revenue in 2024
3.5 Global Key Players of Immune in Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of Immune in Vitro Diagnostics, Product and Application
3.7 Global Key Players of Immune in Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune in Vitro Diagnostics Breakdown Data by Type
4.1 Global Immune in Vitro Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Immune in Vitro Diagnostics Forecasted Market Size by Type (2026-2031)
5 Immune in Vitro Diagnostics Breakdown Data by Application
5.1 Global Immune in Vitro Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Immune in Vitro Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Immune in Vitro Diagnostics Market Size (2020-2031)
6.2 North America Immune in Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Immune in Vitro Diagnostics Market Size by Country (2020-2025)
6.4 North America Immune in Vitro Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune in Vitro Diagnostics Market Size (2020-2031)
7.2 Europe Immune in Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Immune in Vitro Diagnostics Market Size by Country (2020-2025)
7.4 Europe Immune in Vitro Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune in Vitro Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Immune in Vitro Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Immune in Vitro Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Immune in Vitro Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune in Vitro Diagnostics Market Size (2020-2031)
9.2 Latin America Immune in Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Immune in Vitro Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Immune in Vitro Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune in Vitro Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Immune in Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Immune in Vitro Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Immune in Vitro Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Immune in Vitro Diagnostics Introduction
11.1.4 Roche Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Immune in Vitro Diagnostics Introduction
11.2.4 Siemens Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.2.5 Siemens Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Immune in Vitro Diagnostics Introduction
11.3.4 Abbott Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Immune in Vitro Diagnostics Introduction
11.4.4 Danaher Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.4.5 Danaher Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Details
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher Immune in Vitro Diagnostics Introduction
11.5.4 Thermo Fisher Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.5.5 Thermo Fisher Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Details
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Immune in Vitro Diagnostics Introduction
11.6.4 BioMerieux Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.6.5 BioMerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Immune in Vitro Diagnostics Introduction
11.7.4 Bio-Rad Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.7.5 Bio-Rad Recent Development
11.8 BD
11.8.1 BD Company Details
11.8.2 BD Business Overview
11.8.3 BD Immune in Vitro Diagnostics Introduction
11.8.4 BD Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.8.5 BD Recent Development
11.9 KHB
11.9.1 KHB Company Details
11.9.2 KHB Business Overview
11.9.3 KHB Immune in Vitro Diagnostics Introduction
11.9.4 KHB Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.9.5 KHB Recent Development
11.10 Daan Gene
11.10.1 Daan Gene Company Details
11.10.2 Daan Gene Business Overview
11.10.3 Daan Gene Immune in Vitro Diagnostics Introduction
11.10.4 Daan Gene Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.10.5 Daan Gene Recent Development
11.11 Leadman
11.11.1 Leadman Company Details
11.11.2 Leadman Business Overview
11.11.3 Leadman Immune in Vitro Diagnostics Introduction
11.11.4 Leadman Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.11.5 Leadman Recent Development
11.12 Zhongsheng
11.12.1 Zhongsheng Company Details
11.12.2 Zhongsheng Business Overview
11.12.3 Zhongsheng Immune in Vitro Diagnostics Introduction
11.12.4 Zhongsheng Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.12.5 Zhongsheng Recent Development
11.13 Bsbe
11.13.1 Bsbe Company Details
11.13.2 Bsbe Business Overview
11.13.3 Bsbe Immune in Vitro Diagnostics Introduction
11.13.4 Bsbe Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.13.5 Bsbe Recent Development
11.14 Maccura
11.14.1 Maccura Company Details
11.14.2 Maccura Business Overview
11.14.3 Maccura Immune in Vitro Diagnostics Introduction
11.14.4 Maccura Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.14.5 Maccura Recent Development
11.15 Hitachi
11.15.1 Hitachi Company Details
11.15.2 Hitachi Business Overview
11.15.3 Hitachi Immune in Vitro Diagnostics Introduction
11.15.4 Hitachi Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.15.5 Hitachi Recent Development
11.16 Canon
11.16.1 Canon Company Details
11.16.2 Canon Business Overview
11.16.3 Canon Immune in Vitro Diagnostics Introduction
11.16.4 Canon Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.16.5 Canon Recent Development
11.17 Sysmex
11.17.1 Sysmex Company Details
11.17.2 Sysmex Business Overview
11.17.3 Sysmex Immune in Vitro Diagnostics Introduction
11.17.4 Sysmex Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.17.5 Sysmex Recent Development
11.18 Auto Bio
11.18.1 Auto Bio Company Details
11.18.2 Auto Bio Business Overview
11.18.3 Auto Bio Immune in Vitro Diagnostics Introduction
11.18.4 Auto Bio Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.18.5 Auto Bio Recent Development
11.19 Mindray
11.19.1 Mindray Company Details
11.19.2 Mindray Business Overview
11.19.3 Mindray Immune in Vitro Diagnostics Introduction
11.19.4 Mindray Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.19.5 Mindray Recent Development
11.20 Bgi
11.20.1 Bgi Company Details
11.20.2 Bgi Business Overview
11.20.3 Bgi Immune in Vitro Diagnostics Introduction
11.20.4 Bgi Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.20.5 Bgi Recent Development
11.21 Wondfo
11.21.1 Wondfo Company Details
11.21.2 Wondfo Business Overview
11.21.3 Wondfo Immune in Vitro Diagnostics Introduction
11.21.4 Wondfo Revenue in Immune in Vitro Diagnostics Business (2020-2025)
11.21.5 Wondfo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Immune in Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Consumables
 Table 3. Key Players of Equipment
 Table 4. Global Immune in Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Immune in Vitro Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Immune in Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Immune in Vitro Diagnostics Market Share by Region (2020-2025)
 Table 8. Global Immune in Vitro Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Immune in Vitro Diagnostics Market Share by Region (2026-2031)
 Table 10. Immune in Vitro Diagnostics Market Trends
 Table 11. Immune in Vitro Diagnostics Market Drivers
 Table 12. Immune in Vitro Diagnostics Market Challenges
 Table 13. Immune in Vitro Diagnostics Market Restraints
 Table 14. Global Immune in Vitro Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Immune in Vitro Diagnostics Market Share by Players (2020-2025)
 Table 16. Global Top Immune in Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune in Vitro Diagnostics as of 2024)
 Table 17. Ranking of Global Top Immune in Vitro Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Immune in Vitro Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Immune in Vitro Diagnostics, Headquarters and Area Served
 Table 20. Global Key Players of Immune in Vitro Diagnostics, Product and Application
 Table 21. Global Key Players of Immune in Vitro Diagnostics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Immune in Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Immune in Vitro Diagnostics Revenue Market Share by Type (2020-2025)
 Table 25. Global Immune in Vitro Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Immune in Vitro Diagnostics Revenue Market Share by Type (2026-2031)
 Table 27. Global Immune in Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Immune in Vitro Diagnostics Revenue Market Share by Application (2020-2025)
 Table 29. Global Immune in Vitro Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Immune in Vitro Diagnostics Revenue Market Share by Application (2026-2031)
 Table 31. North America Immune in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Immune in Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Immune in Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Immune in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Immune in Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Immune in Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Immune in Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Immune in Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Immune in Vitro Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Immune in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Immune in Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Immune in Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Immune in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Immune in Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Immune in Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Roche Company Details
 Table 47. Roche Business Overview
 Table 48. Roche Immune in Vitro Diagnostics Product
 Table 49. Roche Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 50. Roche Recent Development
 Table 51. Siemens Company Details
 Table 52. Siemens Business Overview
 Table 53. Siemens Immune in Vitro Diagnostics Product
 Table 54. Siemens Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 55. Siemens Recent Development
 Table 56. Abbott Company Details
 Table 57. Abbott Business Overview
 Table 58. Abbott Immune in Vitro Diagnostics Product
 Table 59. Abbott Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 60. Abbott Recent Development
 Table 61. Danaher Company Details
 Table 62. Danaher Business Overview
 Table 63. Danaher Immune in Vitro Diagnostics Product
 Table 64. Danaher Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 65. Danaher Recent Development
 Table 66. Thermo Fisher Company Details
 Table 67. Thermo Fisher Business Overview
 Table 68. Thermo Fisher Immune in Vitro Diagnostics Product
 Table 69. Thermo Fisher Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 70. Thermo Fisher Recent Development
 Table 71. BioMerieux Company Details
 Table 72. BioMerieux Business Overview
 Table 73. BioMerieux Immune in Vitro Diagnostics Product
 Table 74. BioMerieux Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 75. BioMerieux Recent Development
 Table 76. Bio-Rad Company Details
 Table 77. Bio-Rad Business Overview
 Table 78. Bio-Rad Immune in Vitro Diagnostics Product
 Table 79. Bio-Rad Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 80. Bio-Rad Recent Development
 Table 81. BD Company Details
 Table 82. BD Business Overview
 Table 83. BD Immune in Vitro Diagnostics Product
 Table 84. BD Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 85. BD Recent Development
 Table 86. KHB Company Details
 Table 87. KHB Business Overview
 Table 88. KHB Immune in Vitro Diagnostics Product
 Table 89. KHB Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 90. KHB Recent Development
 Table 91. Daan Gene Company Details
 Table 92. Daan Gene Business Overview
 Table 93. Daan Gene Immune in Vitro Diagnostics Product
 Table 94. Daan Gene Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 95. Daan Gene Recent Development
 Table 96. Leadman Company Details
 Table 97. Leadman Business Overview
 Table 98. Leadman Immune in Vitro Diagnostics Product
 Table 99. Leadman Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 100. Leadman Recent Development
 Table 101. Zhongsheng Company Details
 Table 102. Zhongsheng Business Overview
 Table 103. Zhongsheng Immune in Vitro Diagnostics Product
 Table 104. Zhongsheng Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 105. Zhongsheng Recent Development
 Table 106. Bsbe Company Details
 Table 107. Bsbe Business Overview
 Table 108. Bsbe Immune in Vitro Diagnostics Product
 Table 109. Bsbe Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 110. Bsbe Recent Development
 Table 111. Maccura Company Details
 Table 112. Maccura Business Overview
 Table 113. Maccura Immune in Vitro Diagnostics Product
 Table 114. Maccura Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 115. Maccura Recent Development
 Table 116. Hitachi Company Details
 Table 117. Hitachi Business Overview
 Table 118. Hitachi Immune in Vitro Diagnostics Product
 Table 119. Hitachi Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 120. Hitachi Recent Development
 Table 121. Canon Company Details
 Table 122. Canon Business Overview
 Table 123. Canon Immune in Vitro Diagnostics Product
 Table 124. Canon Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 125. Canon Recent Development
 Table 126. Sysmex Company Details
 Table 127. Sysmex Business Overview
 Table 128. Sysmex Immune in Vitro Diagnostics Product
 Table 129. Sysmex Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 130. Sysmex Recent Development
 Table 131. Auto Bio Company Details
 Table 132. Auto Bio Business Overview
 Table 133. Auto Bio Immune in Vitro Diagnostics Product
 Table 134. Auto Bio Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 135. Auto Bio Recent Development
 Table 136. Mindray Company Details
 Table 137. Mindray Business Overview
 Table 138. Mindray Immune in Vitro Diagnostics Product
 Table 139. Mindray Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 140. Mindray Recent Development
 Table 141. Bgi Company Details
 Table 142. Bgi Business Overview
 Table 143. Bgi Immune in Vitro Diagnostics Product
 Table 144. Bgi Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 145. Bgi Recent Development
 Table 146. Wondfo Company Details
 Table 147. Wondfo Business Overview
 Table 148. Wondfo Immune in Vitro Diagnostics Product
 Table 149. Wondfo Revenue in Immune in Vitro Diagnostics Business (2020-2025) & (US$ Million)
 Table 150. Wondfo Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. Immune in Vitro Diagnostics Picture
 Figure 2. Global Immune in Vitro Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Immune in Vitro Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Consumables Features
 Figure 5. Equipment Features
 Figure 6. Global Immune in Vitro Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Immune in Vitro Diagnostics Market Share by Application: 2024 VS 2031
 Figure 8. Hepatitis Test Case Studies
 Figure 9. STD Testing Case Studies
 Figure 10. Tumor Detection Case Studies
 Figure 11. Other Case Studies
 Figure 12. Immune in Vitro Diagnostics Report Years Considered
 Figure 13. Global Immune in Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Immune in Vitro Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Immune in Vitro Diagnostics Market Share by Region: 2024 VS 2031
 Figure 16. Global Immune in Vitro Diagnostics Market Share by Players in 2024
 Figure 17. Global Top Immune in Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune in Vitro Diagnostics as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Immune in Vitro Diagnostics Revenue in 2024
 Figure 19. North America Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Immune in Vitro Diagnostics Market Share by Country (2020-2031)
 Figure 21. United States Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Immune in Vitro Diagnostics Market Share by Country (2020-2031)
 Figure 25. Germany Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Immune in Vitro Diagnostics Market Share by Region (2020-2031)
 Figure 33. China Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Immune in Vitro Diagnostics Market Share by Country (2020-2031)
 Figure 41. Mexico Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Immune in Vitro Diagnostics Market Share by Country (2020-2031)
 Figure 45. Turkey Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Immune in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Roche Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 49. Siemens Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 50. Abbott Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 51. Danaher Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 52. Thermo Fisher Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 53. BioMerieux Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 54. Bio-Rad Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 55. BD Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 56. KHB Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 57. Daan Gene Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 58. Leadman Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 59. Zhongsheng Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 60. Bsbe Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 61. Maccura Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 62. Hitachi Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 63. Canon Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 64. Sysmex Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 65. Auto Bio Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 66. Mindray Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 67. Bgi Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 68. Wondfo Revenue Growth Rate in Immune in Vitro Diagnostics Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS